Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 28 (EEF1A1P28)
- Target
- EEF1A1P28
- Molecular classification
- Other (Pseudogene, non-coding)
01
Overview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 28 (EEF1A1P28) is a processed pseudogene in the human genome, with no protein-coding function. Pseudogenes like EEF1A1P28 are usually the result of retrotransposition events from parental protein-coding genes—in this case, *EEF1A1*, which encodes a major component of the translation machinery. EEF1A1P28 does not produce a protein and currently has no established biological role or clinical association. It is not considered a therapeutic target, nor is it involved in drug interactions, biomarker use, or disease mechanisms as currently understood. Its parental gene, EEF1A1, is involved in translation elongation and has been studied in a variety of disease contexts, particularly cancer, but these associations do not extend specifically to the pseudogene EEF1A1P28.
- Other names
- EEF1A1P28Eukaryotic translation elongation factor 1 alpha 1 pseudogene 28
02
Mechanism of action
None (pseudogene, not targeted by drugs)
03
Biological functions
Other (No known coding function. Pseudogene; does not encode a functional protein.)
04
Disease associations
Other (No direct or established disease association as a pseudogene; studies of parental gene EEF1A1 relate to cancer and other conditions, but not specifically for EEF1A1P28)
Beyond the preview
Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 28 (EEF1A1P28).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 28 (EEF1A1P28).